Chris Beaver joins Pharmanet as Director, Immunochemistry Services

02-Dec-2010 - USA

PharmaNet Development Group, Inc. announced that Chris Beaver, PhD has joined the Company as Director, immunochemistry services. Dr. Beaver is responsible for leading the immunochemistry team within the Company’s bioanalytical laboratories and expanding its large molecule services, including assay development and sample analysis for biomarker, ELISA, radioimmunoassays, immunogenicity and cell-based assays.

Dr. Beaver’s appointment strengthens PharmaNet’s offerings in large molecule bioanalytical services to support the growing interest in biologics and biosimilars within the pharmaceutical industry. PharmaNet has two GLP-compliant bioanalytical laboratories which are located in Princeton, New Jersey and Quebec City, Canada.

Previously, Dr. Beaver served as Scientific Director of Ligand Binding/Cell Based Assays at another clinical research organization with macromolecule bioanalysis operations. He completed his Ph.D. in Neuroscience at Dalhousie University in Halifax, Canada, followed by post-doctoral training at Yale University. Dr. Beaver is published in multiple scientific publications, including Drug Discovery World and Nature Neuroscience.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances